Bibliography
- World Health Organization. The World Health Report 1998a. Life in the 21st century – a vision for all. Available from: http://www.who.int/whr/1998/en/whr98_en.pdf [Accessed November 2007]
- World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2006 global summary. Available from: http://www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf [Accessed November 2007]
- Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11(2):97-107
- World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2004;79(28):253-64
- World Health Organization. Expanded programme on immunization: Global advisory group – Part I. Wkly Epidemiol Rec 1992;67(3):11-5
- Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13(2):302-17
- Bijlmer HA. Epidemiology of Haemophilus influenzae invasive disease in developing countries and intervention strategies. In: Development and Clinical Uses of Haemophilus b Conjugate Vaccines. Ellis RW, Granoff DM, editors. New York: Marcel Dekker; 1994. p. 247-64
- World Health Organization. Global programme for vaccines and immunization. The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 1998b;73(10):64-8
- World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006;81(47):445-52
- World Health Organization. Pertussis vaccines – WHO position paper. Wkly Epidemiol Rec 2005;80(4):31-9
- Arístegui J, Usonis V, Coovadia H, et al. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003;7(2):143-51
- Poovorawan Y, Theamboonlers A, Sanpavat S. The immunogenicity and reactogenicity of combined tetravalent diphtheria, tetanus, pertussis and hepatitis B vaccine in infants. In: Viral Hepatitis and Liver Disease. Nishioka K, Suzuki H, Mishora S, et al. editors. Tokyo: Springer-Verlag; 1994. p. 526-9
- Papaevangelou G, Karvelis E, Alexiou D, et al. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine 1995;13(2):175-8
- Usonis V, Bakasenas V, Taylor D, et al. Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants. Eur J Pediatr 1996;155(3):189-93
- Arístegui J, Garrote E, Gonzàlez A, et al. Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of age. Vaccine 1997;15(1):7-9
- Diez-Delgado J, Dal-Ré R, Llorente M, et al. Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HBV) vaccine: a controlled trial in healthy infants. Vaccine 1997;15(12-13):1418-22
- Lee CY, Lee PI, Huang LM, et al. A simplified schedule to integrate the hepatitis B vaccine into an expanded program of immunization in endemic countries. J Pediatr 1997;130(6):981-6
- Poovorawan Y. Experience of combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B vaccine in Thailand. Southeast Asian J Trop Med Public Health 1997a;28(3):496-9
- Prikazsky V, Vandepapeliere P. Clinical comparison of a combined diphtheria-tetanus-whole-cell pertussis-hepatitis B vaccine with separate administration of DTPw and hepatitis B vaccines in infants. 9th Asian Congress of Paediatrics; 1997 March 23 – 27
- Win KM, Aye M, Htay-Htay H, et al. Comparison of separate and mixed administration of DTPw-HBV and Hib vaccines: immunogenicity and reactogenicity profiles. Int J Infect Dis 1997;2(2):79-84
- Bravo L, Carlos J, Gatchalian S, et al. The new DTPw-HBV-Hib combination vaccine can be used at the WHO schedule with a monovalent dose of hepatitis B vaccine at birth. Southeast Asian J Trop Med Public Health 1998;29(4):772-8
- Chiu HH, Huang LM, Lee PI, et al. Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines: a comparison of two doses (10 microg and 5 microg). Pediatr Infect Dis J 1998;17(3):206-11
- González López A, Aristegui Fernández J, Diez-Delgado J, et al. Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain [In Spanish]. An Esp Pediatr 1998;48(2):132-7
- Prikazsky V, Bock HL. Higher anti-hepatitis B response with combined DTPw-HBV vaccine compared with separate administration in healthy infants at 3, 4 and 5 months of age in Slovakia. Int J Clin Pract 2001;55(3):156-61
- Santos JI, Martin A, De Leon T, et al. DTPw-HBV and Hib primary and booster vaccination: combined versus separate administration to Latin American children. Vaccine 2002;20(13-14):1887-93
- Tregnaghi M, López P, Rocha C, et al. A new DTPw-HBV/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica 2006;19(3):179-88
- Prymula R, David MP, Lefevre I, et al. The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants. Hum Vaccin 2007;3(4):121-6
- Poovorawan Y, Sanpavat S, Pongpunlert W, et al. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 1989;261(22):3278-81
- Poovorawan Y, Theamboonlers A, Sanpavat S, et al. Long-term antibody persistence after booster vaccination with combined tetravalent diphtheria tetanus, whole-cell Bordetella pertussis and hepatitis B vaccine in healthy infants. Ann Trop Paediatr 1997b;17(4):301-8
- Poovorawan Y, Hutagalung Y, Chongsrisawat V, et al. Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age. Vaccine. Submitted
- Usonis V, Bakasenas V, Willems P, et al. Evaluation of the immunogenicity and reactogenicity of a new combined diphtheria, tetanus, whole-cell Bordetella pertussis and hepatitis B vaccine and Haemophilus influenza type b (DTPw-HBV/Hib) vaccine in children at 3, 4.5 and 6 months of age. Acta Med Lithuanica 1999;6(3):187-91
- Ramkissoon A, Coovadia HM, Jugnundan P, et al. A new combined DTP-HBV-Hib vaccine – strategy for incorporation of Hib vaccination into childhood immunisation programmes. S Afr Med J 2001;91(10):864-9
- Faingezicht I, Avila-Aguerro ML, Cervantes Y, et al. Primary and booster vaccination with DTPw-HBV/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine. Rev Panam Salud Publica 2002;12(4):247-57
- López P, Rubiano L, Del Pilar Rubio M, et al. Immunogenicity and reactogenicity of DTPw-HBV/Hib vaccine administered to Colombian infants after a birth dose of hepatitis B vaccine. Expert Rev Vaccines 2002;1(3):277-83
- Riedemann S, Reinhardt G, Jara J, et al. Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months. Int J Infect Dis 2002;6(3):215-22
- Hla KH, Thein SA, Aye A, et al. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Pediatr Infect Dis J 2006;25(8):706-12
- Bavdekar SB, Maiya PP, Subba Rao SD, et al. Immunogenicity and safety of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B/Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr 2007;44(7):505-10
- Ortega-Barrìa E, Kanra G, Leroux G, et al. The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: results from four phase III multicenter trials across three continents. Vaccine 2007;25(50):8432-40
- Gatchalian S, Reyes M, Bernal N, et al. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Hum Vaccin 2005;1(5):198-203
- Gatchalian S, Reyes M, Bernal N, et al. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life. Hum Vaccin (2008) In press
- Available from: http://ctr.gsk.co.uk/medicinelist.asp
- Ducusin J, Davrit E, Simbulan A, et al. A post-marketing surveillance study of a combined diphtheria, tetanus, whole-cell pertussis, and hepatitis B vaccine in the Philippines. Southeast Asian J Trop Med Public Health 2000;31(3):487-92
- Linhares AC, Ruiz-Palacios GM, Guerrero ML, et al. A short report on highlights of world-wide development of RIX4414: a Latin American experience. Vaccine 2006;24(18):3784-5
- Gatchalian S, Palestroque E, De Vleeschauwer I, et al. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components. Int J Infect Dis 2007; [Epub ahead of print]. Published on line 5 November 2007, doi:10.1016/j.ijid.2007.08.007
- Kerdpanich A, Warachit B, Kosuwon P, et al. Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated. Int J Infect Dis 2008;12(1):88-97
- Dagan R, Goldblatt D, Maleckar JR, et al. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components. Infect Immun 2004;72(9):5383-91
- Tormans G, Van Doorslaer E, Van Damme P, et al. Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany. Eur J Pediatr 1998;157(5):395-401
- Chien YC, Jan CF, Kuo HS, et al. Nationwide hepatitis B vaccination program in Taiwan: Effectiveness in the 20 years after it was launched. Epidemiol Rev 2006;28(1):126-35
- Cowgill KD, Ndiritu M, Nyiro J, et al. Effectiveness of Haemophilus influenzae type B conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006;296(6):671-8
- Renner LA, Newman MJ, Ahadzie L, et al. Introduction of Haemophilus influenzae type B conjugate vaccine onto routine immunization in Ghana and its impact on meningitis in children younger than five years. Pediatr Infect Dis J 2007;26(4):356-8
- Shepard DS, Walsh JA, Kleinau E, et al. Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach. Vaccine 1995;13(8):707-14
- Maes E, Van Dijk M, Francois G, et al. Economic aspects of integrating hepatitis B in paediatric combination vaccines. Combined vaccines for the world's children. Progress Towards Implementing Hepatitis b and Haemophilus influenza Type b into Childhood Immunization Programmes; 1999 June 28 – 29, Barcelona, Spain
- Kanra G, Kara A, Demiralp O, et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006;2(4):155-60
- Ali SS, Chandrashekar SR, Singh M, et al. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccin 2007;3(4):116-20
- Raghu MB, Latha R, Bhave S, et al. Immunogenicity and reactogenicity of an indigenous combined diphtheria, tetanus, whole-cell Bordetella pertussis and hepatitis B vaccine in Indian infants. J Trop Pediatr 2005;51(4):261
- Wenger J. Vaccines for the developing world: current status and future directions. Vaccine 2001;19(13-14):1588-91
- World Health Organization. The children's vaccine initiative and the global programme for vaccines and immunization. Recommendations from the special advisory group of experts. Part II. Wkly Epidemiol Rec 1996;71(36):269-73
- Centers for Disease Control and Prevention. Combination vaccines for childhood immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians. MMWR Recomm Rep 1999;48(RR-5):1-14
- Bogaerts H. The future of childhood immunizations: examining the European experience. Am J Manag Care 2003;9(1 Suppl):S30-6
- Dodd D. Benefits of combination vaccines: effective vaccination on a simplified schedule. Am J Manag Care 2003;9(1 Suppl):S6-12
- Kalies H, Grote V, Verstraeten T, et al. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006;25(6):505-12
- Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007;26(6):496-500
- Edwards KM. Acellular pertussis vaccines-a solution to the pertussis problem? J Infect Dis 1993;168(1):15-20
- Lopez AL, Blumberg DA. An overview of the status of acellular pertussis vaccines in practice. Drugs 1997;54(2):189-96
- Cody CL, Baraff LJ, Cherry JD, et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981;68(5):650-60
- Gustafsson L, Hallander HO, Olin P, et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole cell pertussis vaccine. N Engl J Med 1996;334(6):349-55